16 August 2016 - The government was repeatedly warned that drug companies were buying the rights to old drugs, discontinuing a brand name and raising the price.
Doctors, academics and NHS staff highlighted the excessive cost of some generic drugs two years ago but health officials failed to stop huge price rises.
The government was repeatedly warned that drug companies were buying the rights to old drugs, discontinuing a brand name and raising the price.
NHS officials in Manchester and Lincolnshire separately issued documents focusing on a large number of price rises in drugs marketed by one British firm, AMCo, now known as Concordia International.